AN EASY WAY TO PREVENT VELOCITY-RELATED COMPLICATIONS DURING DEXAMETHASONE IMPLANT INJECTION IN VITRECTOMIZED EYES

dc.contributor.authorOzturk, Emrah
dc.contributor.authorAdam, Mehmet
dc.contributor.authorOzdemir, Huseyin Baran
dc.date.accessioned2026-04-04T13:33:27Z
dc.date.available2026-04-04T13:33:27Z
dc.date.issued2025
dc.departmentİnönü Üniversitesi
dc.description.abstractPurpose:To assess the impact of inserting an ophthalmic viscoelastic device into the dexamethasone (DEX) implant needle on pellet velocity in simulated vitrectomized eyes.Methods:Dexamethasone implants were injected into a calibrated ex vivo test chamber filled with balanced salt solution. All DEX implants were administered by the same physician, aiming for the same button depression time. In Group 1, three DEX implant injections were performed without an ophthalmic viscoelastic device, while in Group 2, the ophthalmic viscoelastic device was safely inserted into the DEX implant needle using a 27-gauge cannula just before the injection. The slow-motion video mode of the IPhone 14 was used to record the procedures and calculate time and distance measurements.Results:Group 1 exhibited a mean velocity of 450 mm/second for the DEX pellet in balanced salt solution, compared with 54.57 mm/second in Group 2. Furthermore, DEX pellets in Group 1 had horizontal displacements of 24, 29, and 31 mm, while those in Group 2 had displacements of 17, 16, and 15 mm.Conclusion:Injecting an ophthalmic viscoelastic device into the DEX implant needle significantly decreases the velocity of the free pellet in balanced salt solution by 87.87%. This modification may help prevent potential velocity-related complications linked to DEX implantation in vitrectomized eyes.
dc.identifier.doi10.1097/IAE.0000000000004267
dc.identifier.endpage329
dc.identifier.issn0275-004X
dc.identifier.issn1539-2864
dc.identifier.issue2
dc.identifier.orcid0000-0002-3590-3213
dc.identifier.pmid39284032
dc.identifier.scopus2-s2.0-85204913661
dc.identifier.scopusqualityQ1
dc.identifier.startpage325
dc.identifier.urihttps://doi.org/10.1097/IAE.0000000000004267
dc.identifier.urihttps://hdl.handle.net/11616/109167
dc.identifier.volume45
dc.identifier.wosWOS:001406006000016
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofRetina-The Journal of Retinal and Vitreous Diseases
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250329
dc.subjectcomplication
dc.subjectdexamethasone
dc.subjectophthalmic viscoelastic device
dc.subjectozurdex
dc.subjectvelocity
dc.subjectvitrectomized eye
dc.titleAN EASY WAY TO PREVENT VELOCITY-RELATED COMPLICATIONS DURING DEXAMETHASONE IMPLANT INJECTION IN VITRECTOMIZED EYES
dc.typeArticle

Dosyalar